GDNF and amyotrophic lateral sclerosis: Li [94] and Suzuki et al. [95] have demonstrated that the intramuscular administration of muscle (not centrally)-derived GDNF resulted in a higher number of preserved innervated neuromuscular junctions and surviving MNs, even at later stages of ALS.